What is the Prognosis for Autoimmune Gastritis?
At a Glance
The prognosis for autoimmune gastritis is generally positive and does not typically reduce life expectancy. While it is a lifelong condition that requires regular blood tests and endoscopies to monitor for vitamin deficiencies and stomach tumors, it can be effectively managed with proactive care.
In this answer
3 sections
The prognosis for autoimmune gastritis (AIG) is generally positive, provided the condition is consistently monitored and managed [1][2]. AIG is a chronic, lifelong condition. While the medical literature does not indicate it significantly reduces life expectancy on its own [3][4], it can lead to complications that require proactive medical care. Because the immune system slowly damages the cells in the stomach lining, patients are at risk for nutritional deficiencies and, over time, specific types of stomach tumors [1][5][6]. With appropriate vitamin and mineral supplementation, along with regular medical surveillance, most people with AIG can effectively manage their condition.
Understanding Disease Progression
AIG typically progresses slowly. Many patients begin in a “potential” stage, which can evolve over several years into “overt” AIG, where the stomach lining becomes significantly thinned (atrophy) [4][7]. This progression is seen more frequently in individuals who have other autoimmune disorders [7]. As the stomach cells (parietal cells) are damaged, the stomach loses its ability to produce stomach acid and a protein called intrinsic factor, which are both essential for absorbing certain nutrients.
Long-Term Complications to Watch For
While some people with AIG do not experience daily symptoms, the lack of stomach acid can cause day-to-day digestive issues like bloating or indigestion. Beyond these daily symptoms, the physical changes in the stomach can lead to several distinct long-term complications.
Nutritional Deficiencies and Pernicious Anemia
The most common long-term consequences of AIG are deficiencies in iron and vitamin B12 [5][8]. Because stomach acid is required to properly absorb iron from food, iron deficiency often appears earlier in the disease process. Later, as the stomach stops producing intrinsic factor, the body loses its ability to absorb vitamin B12. Over time, a severe B12 deficiency can lead to pernicious anemia (a condition where the body cannot make enough healthy red blood cells) and neurological problems, such as numbness, tingling, or balance issues [1][9]. Regular screening and treatment with vitamin B12 (often injections or high-dose oral supplements) and iron supplementation (pills or infusions) easily manage this risk [1][10].
Gastric Neuroendocrine Tumors (gNETs)
Because the stomach is producing less acid, the body tries to compensate by overproducing a hormone called gastrin [11][12]. High levels of gastrin in the blood (hypergastrinemia) can stimulate certain cells in the stomach, increasing the risk of developing Type 1 gastric neuroendocrine tumors (gNETs) [13][11]. While the word “tumor” is frightening, Type 1 gNETs are usually slow-growing and have a very low risk of spreading, though they require medical monitoring or endoscopic removal [6][14]. Risk factors for developing these tumors include being male, having elevated levels of a marker called chromogranin A, and having cellular changes in the stomach called intestinal metaplasia (when stomach cells transform to look like intestinal cells) [15].
Gastric Adenocarcinoma
AIG is considered a precancerous condition, meaning it carries an increased risk for gastric adenocarcinoma (stomach cancer) compared to a completely healthy stomach [13][1]. However, recent medical studies offer conflicting views on exactly how high this risk is. Some research suggests the risk of developing stomach cancer is actually very low and may not be significantly higher than in the general population [4][16][17]. Other studies emphasize a persistent risk that warrants close monitoring, especially in patients over 60 years old or those who have developed pernicious anemia or intestinal metaplasia [18][19].
Other Autoimmune Conditions
Having AIG increases the likelihood of developing other autoimmune diseases. It is frequently associated with autoimmune thyroid disease (like Hashimoto’s thyroiditis) and Type 1 diabetes [20][21][22]. Doctors will often actively screen for these related conditions so they can be diagnosed and managed early [23][24].
How AIG is Monitored Over Time
Because of the long-term risks, lifelong monitoring is an essential part of the prognosis for AIG [2][1]. The standard of care typically involves:
- Regular Blood Tests: Your doctor will periodically check your vitamin B12, iron, and hemoglobin levels to prevent or manage anemia [5]. They may also monitor serum gastrin and chromogranin A levels, which can help identify if you are at a higher risk for developing gNETs [25][15].
- Endoscopic Surveillance: An upper endoscopy (often called an EGD) is the primary tool for monitoring the health of your stomach lining. During this procedure, a doctor looks inside the stomach and takes small tissue samples (biopsies) [1][26]. While specific standardized guidelines are still evolving, doctors often recommend an endoscopy every 3 to 5 years. Your exact schedule will be personalized based on risk factors such as the presence of polyps, intestinal metaplasia, dysplasia (abnormal precancerous cells), or severe vitamin B12 deficiency [27][14][28].
Common questions in this guide
Does autoimmune gastritis affect life expectancy?
How often should I get an endoscopy for autoimmune gastritis?
What are the long-term complications of autoimmune gastritis?
Will I develop other autoimmune conditions if I have autoimmune gastritis?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.What stage of atrophy is my stomach currently in based on my recent endoscopy?
- 2.Did my biopsy show any signs of intestinal metaplasia or dysplasia?
- 3.How frequently do you recommend I have an upper endoscopy, and what specific findings would change that timeline?
- 4.Are my iron and vitamin B12 levels currently stable, and should I adjust how I supplement them?
- 5.Based on my diagnosis, should I be screened for other autoimmune conditions like Hashimoto's thyroiditis or Type 1 diabetes?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (28)
- 1
Autoimmune Atrophic Gastritis: A Clinical Review.
Castellana C, Eusebi LH, Dajti E, et al.
Cancers 2024; (16(7)) doi:10.3390/cancers16071310.
PMID: 38610988 - 2
Unraveling the Mysteries of Autoimmune Gastritis.
Soykan İ, Er RE, Baykara Y, Kalkan C
The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology 2024; (36(3)):135-144 doi:10.5152/tjg.2024.24563.
PMID: 39632655 - 3
Pediatric autoimmune gastritis: clinical correlates and histologic features.
Kulak O, Gurram B, Montgomery EA, Park JY
Human pathology 2021; (116()):31-38 doi:10.1016/j.humpath.2021.07.002.
PMID: 34284050 - 4
Long-Term Natural History of Autoimmune Gastritis: Results From a Prospective Monocentric Series.
Miceli E, Lenti MV, Gentile A, et al.
The American journal of gastroenterology 2024; (119(5)):837-845 doi:10.14309/ajg.0000000000002619.
PMID: 38050966 - 5
Iron and Vitamin B12 Deficiency in Patients with Autoimmune Gastritis and Helicobacter pylori Gastritis: Results from a Prospective Multicenter Study.
Osmola M, Chapelle N, Vibet MA, et al.
Digestive diseases (Basel, Switzerland) 2024; (42(2)):145-153 doi:10.1159/000535206.
PMID: 38198775 - 6
Autoimmune metaplastic atrophic gastritis and association with neuroendocrine tumors of the stomach.
Nehme F, Rowe K, Palko W, et al.
Clinical journal of gastroenterology 2020; (13(3)):299-307 doi:10.1007/s12328-019-01074-7.
PMID: 31782113 - 7
Time course and risk factors of evolution from potential to overt autoimmune gastritis.
Lenti MV, Miceli E, Vanoli A, et al.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2022; (54(5)):642-644 doi:10.1016/j.dld.2021.10.001.
PMID: 34732311 - 8
Determinants of diagnostic delay in autoimmune atrophic gastritis.
Lenti MV, Miceli E, Cococcia S, et al.
Alimentary pharmacology & therapeutics 2019; (50(2)):167-175 doi:10.1111/apt.15317.
PMID: 31115910 - 9
[A case of subacute combined degeneration of the spinal cord caused by autoimmune gastritis misdiagnosed with repeated failures of Helicobacter pylori eradication].
Umehara F
Rinsho shinkeigaku = Clinical neurology 2025; (65(9)):661-665 doi:10.5692/clinicalneurol.cn-002126.
PMID: 40866231 - 10
A Retrospective Study on Clinical Features of Autoimmune Gastritis: Impact of Age, Sex, and Autoimmune Thyroid Disease in China.
Wang X, Lu CJ, Ding Y, et al.
Gut and liver 2025; (19(4)):528-535 doi:10.5009/gnl240448.
PMID: 39943807 - 11
Do Gastric Signet Ring Cell Carcinomas and ECL-Cell Neuroendocrine Tumours Have a Common Origin?
Fossmark R, Johannessen R, Qvigstad G, Mjønes P
Medicina (Kaunas, Lithuania) 2022; (58(4)) doi:10.3390/medicina58040470.
PMID: 35454309 - 12
The central role of gastrin in gastric cancer.
Waldum H, Mjønes P
Frontiers in oncology 2023; (13()):1176673 doi:10.3389/fonc.2023.1176673.
PMID: 37941554 - 13
Multifocal early gastric cancer in a patient with atrophic gastritis and pernicious anemia.
Zurleni T, Altomare M, Serio G, Catalano F
International journal of surgery case reports 2020; (72()):433-437 doi:10.1016/j.ijscr.2020.06.010.
PMID: 32563836 - 14
Case Report: Concurrent autoimmune gastritis and high-grade dysplasia in a gastric hyperplastic polyp.
Wang T, Luo J, Han Y, et al.
Frontiers in medicine 2025; (12()):1716969 doi:10.3389/fmed.2025.1716969.
PMID: 41601724 - 15
Risk factors of type 1 gastric neuroendocrine neoplasia in patients with chronic atrophic gastritis. A retrospective, multicentre study.
Campana D, Ravizza D, Ferolla P, et al.
Endocrine 2017; (56(3)):633-638 doi:10.1007/s12020-016-1099-y.
PMID: 27592118 - 16
Autoimmune gastritis may be less susceptible to cancer development than Helicobacter pylori-related gastritis based on histological analysis.
Arai J, Niikura R, Hayakawa Y, et al.
Gut 2024; (73(6)):1037-1038 doi:10.1136/gutjnl-2023-330052.
PMID: 37197906 - 17
Distinct Features of Autoimmune Gastritis in Patients with Open-Type Chronic Gastritis in Japan.
Tsuboi M, Niikura R, Hayakawa Y, et al.
Biomedicines 2020; (8(10)) doi:10.3390/biomedicines8100419.
PMID: 33066474 - 18
Incidence and Predictors of Gastric Neoplastic Lesions in Corpus-Restricted Atrophic Gastritis: A Single-Center Cohort Study.
Dilaghi E, Dottori L, Pivetta G, et al.
The American journal of gastroenterology 2023; (118(12)):2157-2165 doi:10.14309/ajg.0000000000002327.
PMID: 37207305 - 19
Endogenous Glucocorticoids Moderate the Gastric Inflammatory Response to Helicobacter Infection and Protect from Autoimmunity.
Druffner SR, Duncan BC, Morris MT, et al.
Cellular and molecular gastroenterology and hepatology 2026; (20(4)):101699 doi:10.1016/j.jcmgh.2025.101699.
PMID: 41453637 - 20
[Endoscopic treatment for gastric carcinoid tumor in a patient with type A gastritis complicated with autoimmune polyendocrine syndrome: a case report].
Mie T, Ohta T, Iwamoto T, et al.
Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 2019; (116(8)):654-659 doi:10.11405/nisshoshi.116.654.
PMID: 31406070 - 21
Pathophysiology and laboratory diagnosis of pernicious anemia.
Toh BH
Immunologic research 2017; (65(1)):326-330 doi:10.1007/s12026-016-8841-7.
PMID: 27538411 - 22
Revisiting autoimmune gastritis in children and adolescents with type 1 diabetes.
Besançon A, Michaud B, Beltrand J, et al.
Pediatric diabetes 2017; (18(8)):772-776 doi:10.1111/pedi.12482.
PMID: 28004477 - 23
Polyautoimmunity in autoimmune gastritis.
Kalkan Ç, Soykan I
European journal of internal medicine 2016; (31()):79-83.
PMID: 27085391 - 24
Autoimmune Gastritis in Pediatrics: A Review of 3 Cases.
Mitsinikos T, Shillingford N, Cynamon H, Bhardwaj V
Journal of pediatric gastroenterology and nutrition 2020; (70(2)):252-257 doi:10.1097/MPG.0000000000002547.
PMID: 31978028 - 25
Serum Gastrin Levels Are Associated With Prevalent Neuroendocrine Tumors in Autoimmune Metaplastic Atrophic Gastritis.
Jove A, Lin C, Hwang JH, et al.
The American journal of gastroenterology 2025; (120(5)):1140-1143 doi:10.14309/ajg.0000000000003235.
PMID: 39588964 - 26
Occurrence and characteristics of endoscopic gastric polyps in patients with autoimmune gastritis (AGAPE study): A multicentric cross-sectional study.
Massironi S, Gallo C, Lahner E, et al.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2025; (57(1)):198-205 doi:10.1016/j.dld.2024.07.024.
PMID: 39112216 - 27
Case Report: A rare hyperplastic polyp with synchronous high-grade intraepithelial neoplasia in both glandular and squamous epithelium in autoimmune gastritis.
Zhang D, Chen X, Hendi M, et al.
Frontiers in oncology 2025; (15()):1641188 doi:10.3389/fonc.2025.1641188.
PMID: 40896425 - 28
Distinguishing Features of Autoimmune Gastritis Depending on Previous Helicobacter pylori Infection or Positivity to Anti-Parietal Cell Antibodies: Results From the Autoimmune gastRitis Italian netwOrk Study grOup (ARIOSO).
Lenti MV, Miceli E, Lahner E, et al.
The American journal of gastroenterology 2024; (119(12)):2408-2417 doi:10.14309/ajg.0000000000002948.
PMID: 38976374
This page explains the prognosis and monitoring of autoimmune gastritis for informational purposes. Always consult your gastroenterologist for personalized medical advice regarding your condition and endoscopy schedule.
Get notified when new evidence is published on autoimmune gastritis.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.